Research progress on restarting anticoagulant therapy for anticoagulation related cerebral hemorrhage
10.3760/cma.j.cn431274-20230927-00329
- VernacularTitle:抗凝相关脑出血重启抗凝治疗的研究进展
- Author:
Xufeng PAN
1
;
Rong WU
;
Haifei CHAI
;
Jie WANG
;
Xiaoming HU
Author Information
1. 浙江省台州医院神经外科，台州 317000
- Keywords:
Anticoagulants;
Cerebral hemorrhage;
Restart
- From:
Journal of Chinese Physician
2024;26(8):1273-1276
- CountryChina
- Language:Chinese
-
Abstract:
With the aging population, the burden of diseases such as atrial fibrillation and venous thrombosis is gradually increasing. Anticoagulant therapy has a positive significance in preventing ischemic stroke, pulmonary embolism, and other related conditions in these patients. However, anticoagulant therapy can have the opposite effect on diseases caused by intracranial hemorrhage, such as falls in the elderly, cerebrovascular accidents, and car accidents. It is still difficult to determine whether and when to restart anticoagulation after cerebral hemorrhage. Although most studies have shown that restarting anticoagulant therapy can reduce stroke risk without significantly increasing bleeding risk, they are mostly based on observational studies, so more high-quality research is needed to guide clinical decision-making. This article reviews the research progress on restart anticoagulation, aiming to provide some assistance for clinical applications.
